A Multicenter, Randomized, Double-Blind, Controlled Phase 3, Efficacy And Safety Study Of Sunitinib (SU011248) In Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Treated With Erlotinib
A Multicenter, Randomized, Double-Blind, Controlled Phase 3, Efficacy And Safety Study Of Sunitinib (SU011248) In Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Treated With Erlotinib
This study will test whether treatment with erlotinib plus SU011248 is better than erlotinib alone in patients with advanced/metastatic lung cancer who have received previous treatment with a platinum-based regimen.
Inclusion Criteria:
Exclusion Criteria:
Ostrava-Poruba, 708 52, Czechia
Pribram V, 261 95, Czechia
Hilleroed, 3400, Denmark
Koebenhavn OE, 2100, Denmark
Kifisia, Athens, 145 64, Greece
Zalaegerszeg-Pozva, H-8900, Hungary
Kvetnica Pri Poprade, 058 87, Slovakia
Nitra-Zobor, 949 88, Slovakia
Gwei Shan Township, Taoyuan County 333, Taiwan
Pathumwan, Bangkok 10330, Thailand
Amphoe Mueang, Chiang Mai 50200, Thailand
Bebington, Wirral, CH63 4JY, United Kingdom